Dopamine Receptor d1 anticorps (C-Term)
Aperçu rapide pour Dopamine Receptor d1 anticorps (C-Term) (ABIN363247)
Antigène
Voir toutes Dopamine Receptor d1 (DRD1) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- C-Term
-
Specificité
- Reacts with mouse and rat Dopamine Receptor D1A
-
Réactivité croisée
- Lapin, Mouton
-
Réactivité croisée (Details)
- Do not react with human, dog, pig, sheep, rabbit, or cow proteins. Do not cross react with D1B (D5) receptor.
-
Purification
- Purified (protein A)
-
Immunogène
- Recombinant rat D1 (D1A) dopamine receptor (123 residues with 23 residues near the C-terminus)
-
Isotype
- IgG2b kappa
-
-
-
-
Indications d'application
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only :
- ICC : 2 μg/mL - IF : 2 μg/mL - WB : 2 μg/mL -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1.4 mg/mL
-
Buffer
- Tris-glycine, NaCl 150 mM buffer, Sodium azide 0.05 %
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C/-80 °C
-
Stockage commentaire
- Aliquot and store at -20°C or -80°C. Avoid freeze-thaw cycles.
-
-
- Dopamine Receptor d1 (DRD1) (Dopamine Receptor D1 (DRD1))
-
Autre désignation
- Dopamine D1 Receptor
-
Pathways
- cAMP Metabolic Process, Inositol Metabolic Process, Protein targeting to Nucleus, Feeding Behaviour, Smooth Muscle Cell Migration, Regulation of long-term Neuronal Synaptic Plasticity
Antigène
-